China's state-owned Eastern Airlines said on Friday its net loss shrank to 4.2 billion yuan ($578 million) in 2024 from a 8.2 ...

Novo Nordisk shares have fallen 25% so far in March and are on track for their biggest monthly drop since July 2002, as ...

President Donald Trump continues to warn of tariffs on the pharmaceutical industry; Susan Monarez replaces Dave Weldon as CDC ...

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...

Novo Nordisk has acquired the global rights to China-based United Laboratories’ triple-agonist weight-loss and diabetes drug ...

Merck has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion, ...

Rafe Uddin So Starlink’s role in a number of European countries means that it’s seen as an easy target, given Musk’s proximity to Trump. There are also fears about a peace settlement between Russia ...

Building upon its already impressive obesity drug portfolio, Novo Nordisk A/S has licensed a triple agonist of the receptors for GLP-1, GIP and glucagon from United Biotechnology Co. Ltd. China-based ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

As part of the agreement with a United Lab unit announced on Monday, Novo will make an upfront payment of $200 million and up ...

German software company SAP overtook Danish healthcare company Novo Nordisk as Europe's largest company by market ...

We will probably not have any clarification on how the reciprocal tariffs will play out until April 2 — provided Trump isn’t ...